/PDRX

PDRX Stock - PD-Rx Pharmaceuticals, Inc.

Q: What is the analyst price target for PDRX?

Analyst price target information is not currently available for PDRX.

Q: What is PDRX's market cap?

Market capitalization information is not currently available for PDRX.

Healthcare|Medical - Distribution|OTC

$2.85+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $3.14

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for PDRX

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-1366978.48

52W High$3.05

52W Low$2.41

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	$18.95M	$21.27M	$28.72M	$21.60M	$21.03M
Gross Profit	$5.62M	$6.71M	$11.06M	$6.96M	$6.26M
Gross Margin	29.7%	31.6%	38.5%	32.2%	29.8%
Operating Income	$-952,018	$-190,477	$4.00M	$876,470	$-237,650
Net Income	$-753,495	$-98,064	$3.03M	$1.86M	$-384,141
Net Margin	-4.0%	-0.5%	10.6%	8.6%	-1.8%
EPS	$-0.46	$-0.06	$1.83	$1.08	$-0.22

Company Overview

PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company provides approximately 2,600 prepackaged medications; and creams, ointments, ophthalmics, otics, liquids, suspensions, etc. It also offers PD-Rx Net, a web-based application that tracks prescriptions filled at the point of care and print prescription labels for prescription that filled onsite; and manual dispensing system that provides 10 recordkeeping labels to match the 10 bottle trays as a convenient handling package for physician dispensing customers. In addition, the company provides professional assistance by staffed pharmacists and physicians; and pharmaceutical sampling program design to reduce MCO's pharmaceutical costs, as well as allows medical professionals to offer pre-filled prescriptions to patients free of charge. It serves physicians, pharmacies, and medical clinics. PD-Rx Pharmaceuticals, Inc. was incorporated in 1986 and is headquartered in Oklahoma City, Oklahoma.

Visit Website

Frequently Asked Questions about PDRX

What is PDRX's current stock price?

PD-Rx Pharmaceuticals, Inc. (PDRX) is currently trading at $2.85 per share. The stock has moved +0.00% today.

What is the analyst price target for PDRX?

No analyst price targets are currently available for this stock.

What sector is PD-Rx Pharmaceuticals, Inc. in?

PD-Rx Pharmaceuticals, Inc. operates in the Healthcare sector, specifically within the Medical - Distribution industry. The company is traded on the OTC exchange.

What is PDRX's market cap?

PD-Rx Pharmaceuticals, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does PDRX pay dividends?

No, PD-Rx Pharmaceuticals, Inc. does not currently pay a dividend to shareholders.